XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
115 hedge funds and large institutions have $956M invested in Acceleron Pharma in 2015 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 40 increasing their positions, 31 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
14% less call options, than puts
Call options by funds: $5.99M | Put options by funds: $6.99M
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Holders
115
Holding in Top 10
5
Calls
$5.99M
Puts
$6.99M
Top Buyers
| 1 | +$18.2M | |
| 2 | +$18.1M | |
| 3 | +$6.23M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$5.13M |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
+$4.01M |
Top Sellers
| 1 | -$21.8M | |
| 2 | -$9.02M | |
| 3 | -$7.63M | |
| 4 |
PVMCI
Polaris Venture Management Co IV
Boston,
Massachusetts
|
-$7M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$5.28M |